FAN-CHI CHANGKAO-LANG LIUKUO-HOW HUANGVIN-CENT WUYEN-HUNG LINYUNG-MING CHENKWAN-DUN WU2020-03-272020-03-2720120929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/479460Adrenalectomy is the definite treatment for aldosterone-producing adenoma (APA). Percutaneous ethanol or acetic acid injection with computed tomography (CT) guidance has been described as a safe, noninvasive, and effective alternative treatment modality in patients with high surgical risk. We report on a man who was 49 years of age and presented with treatment-resistant hypertension and was later diagnosed with APA. CT-guided percutaneous ethanol injection (PEI) was performed for this high surgical risk patient. He had aldosteronism recurrence 4 years after the ethanol injection, so a second PEI was performed. The tumor size was reduced and his blood pressure was normalized. Therefore, we suggest that clinicians should closely check aldosterone to renin ration and potassium level if percutaneous chemical ablation is considered in functioning adrenal adenomas. ? 2012, Elsevier Taiwan LLC & Formosan Medical Association.[SDGs]SDG3alcohol; aldosterone; sodium chloride; spironolactone; adrenal cortex adenoma; adrenal tumor; adult; aldosterone blood level; article; blood pressure; case report; computer assisted tomography; human; hypertension; nuclear magnetic resonance imaging; primary hyperaldosteronism; recurrent disease; surgical risk; systolic blood pressure; tumor volume; Adenoma; Administration, Cutaneous; Adrenal Gland Neoplasms; Ethanol; Humans; Hyperaldosteronism; Male; Middle Aged; Recurrencejournal article10.1016/j.jfma.2012.01.009224236722-s2.0-84862779423